SCIEX is a leading manufacturer of mass spectrometry instrumentation, primarily used in biomedical and environmental applications. Established in 1974 by scientists and a businessman from the University of Toronto Institute for Aerospace Studies, SCIEX developed innovative mass spectrometer systems based on atmospheric pressure ionization and direct air sampling.
Since its founding, SCIEX has been at the forefront of analytical technology for over 50 years, introducing the first commercially successful triple quadrupole mass spectrometer in 1981. Its technologies empower scientists globally to tackle complex challenges in quantitation and characterization, essential for life-changing research outcomes.
The company offers a comprehensive portfolio of products including mass spectrometers, capillary electrophoresis instruments, and chromatography solutions such as HPLC, designed with user applications in mind. SCIEX emphasizes ease of data interpretation, workflow optimization, and expert technical support.
SCIEX is part of Danaher Corporation, a science and technology leader, which enhances its capabilities and market reach. This relationship allows SCIEX to leverage Danaher’s breadth of expertise in biotechnology, diagnostics, and life sciences, aiming to improve billions of lives through cutting-edge scientific innovations.
Operating globally, SCIEX serves diverse fields including life science research, drug discovery and development, clinical diagnostics, forensics, and food and environmental testing. Their mission is to deliver precise and reliable data to enable critical scientific decisions and discoveries.